Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer

The Journal of Steroid Biochemistry and Molecular Biology
Elizabeth T JacobsJames R Marshall

Abstract

In the US, prostate cancer (PCa) has the highest incidence rate of all cancers in males, with few known modifiable risk factors. Some studies support an association between the Vitamin D metabolites, 1,25-dihydroxyvitamin D (1alpha,25(OH)(2)D(3)) and/or 25-hydroxyvitamin D (25(OH)D(3)), and prostate cancer, while others have yielded conflicting results. 1alpha,25(OH)(2)D(3) has anti-proliferative and pro-differentiating effects in prostate cancer cell lines, and levels of circulating 25(OH)D(3) may be important as PCa cells possess 1-alpha-hydroxylase activity. Using a nested case-control design, we evaluated whether plasma levels of 25(OH)D(3) and 1alpha,25(OH)(2)D(3) were associated with prostate cancer risk in participants from the Nutritional Prevention of Cancer (NPC) trial. With 83 cases and 166 matched controls, we calculated the adjusted odds ratios for increasing plasma levels of 25(OH)D(3) and 1alpha,25(OH)(2)D(3). Compared to the lowest tertile of plasma 25(OH)D(3) levels, the adjusted odds ratios were 1.71 (0.68-4.34) and 0.75 (0.29-1.91); the corresponding odds ratios for 1alpha,25(OH)(2)D(3) were 1.44 (0.59-3.52) and 1.06 (0.42-2.66). Given the pivotal effects of the Vitamin D receptor on gene transcription, it is...Continue Reading

References

May 1, 1995·Cancer Causes & Control : CCC·M M BraunG W Comstock
Oct 6, 1993·Journal of the National Cancer Institute·E GiovannucciW C Willett
Jan 15, 1997·Journal of the National Cancer Institute·S A InglesG A Coetzee
Mar 31, 1998·Lancet·A MalabananM F Holick
Apr 3, 1998·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M R HausslerP W Jurutka
May 30, 1998·Proceedings of the Society for Experimental Biology and Medicine·E Giovannucci, S K Clinton
Oct 12, 2000·Molecular and Cellular Endocrinology·V Sung, D Feldman
Nov 15, 2000·Cancer Causes & Control : CCC·M H AhonenP Tuohimaa
Aug 14, 2001·Journal of Cellular Biochemistry·D KrillR H Getzenberg
Oct 9, 2001·Epidemiologic Reviews·J M Chan, E L Giovannucci
Dec 12, 2002·Urology·Sonja I BerndtUNKNOWN Baltimore Longitudinal Study of Aging
Feb 6, 2003·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Jul 13, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J E P RockellT J Green
Apr 21, 2009·Cancer Causes & Control : CCC·C HalthurP W Dickman
Apr 13, 2010·Cancer Causes & Control : CCC·Christine M BarnettTomasz M Beer
Jun 19, 2012·Cancer Causes & Control : CCC·Johan BrändstedtJohan Malm
Oct 29, 2009·Nutrition Research Reviews·Sihe Wang
Apr 17, 2012·Asian Journal of Andrology·Kathryn M WilsonLorelei A Mucci
Mar 4, 2009·Carcinogenesis·Jiyoung AhnUNKNOWN Prostate, Lung, Colorectal and Ovarian Trial Project Team
May 29, 2008·Journal of the National Cancer Institute·Jiyoung AhnUNKNOWN Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team
Sep 5, 2009·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Han van der RheeEsther de Vries
Aug 29, 2007·Acta Pharmacologica Sinica·Fazlul H Sarkar, Yi-wei Li
Jul 26, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Demetrius AlbanesStephanie J Weinstein
May 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Whitney K HendricksonEdward Giovannucci
Mar 28, 2008·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Donald T WigleMarie-Elise Parent
Dec 5, 2008·Nutrition Reviews·Pentti Tuohimaa
Apr 3, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·D Michal FreedmanRegina G Ziegler
Mar 5, 2016·Frontiers in Immunology·Ken BataiRick A Kittles
Oct 22, 2011·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Mariela VarsavskyManuel Muñoz-Torres
Jul 30, 2011·The Urologic Clinics of North America·Christine M Barnett, Tomasz M Beer
Nov 27, 2009·Cancer Epidemiology·Lu YinHermann Brenner
Feb 23, 2008·Annals of Epidemiology·Edward Giovannucci
May 18, 2010·International Journal of Cancer. Journal International Du Cancer·Sara GandiniPhilippe Autier
Dec 7, 2011·BJU International·Tim W LokeMohamed Khadra
Oct 21, 2006·Journal of the American Academy of Dermatology·Shayla O FrancisRobert P Dellavalle
Jun 22, 2005·European Urology·Alessandra TavaniCarlo La Vecchia
Dec 15, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Han van der RheeEsther de Vries
Mar 5, 2011·Molecular Oncology·Sinead Field, Julia A Newton-Bishop
Jun 25, 2016·World Journal of Urology·Alison M MondulDemetrius Albanes
Jun 1, 2012·The American Journal of Clinical Nutrition·Rachel HurstSusan J Fairweather-Tait
Jan 10, 2018·Cold Spring Harbor Perspectives in Medicine·Claire H PernarLorelei A Mucci
Jul 13, 2007·The Prostate·Zoya LagunovaJohan Moan
May 4, 2005·Cancer Causes & Control : CCC·Edward Giovannucci
Dec 10, 2009·Nature Reviews. Urology·Greg TrottierNeil E Fleshner
Jan 16, 2014·The Journal of Clinical Endocrinology and Metabolism·Karin AmreinKenneth B Christopher
Apr 6, 2006·Journal of the National Cancer Institute·Edward GiovannucciWalter C Willett
Mar 14, 2007·The British Journal of Nutrition·Jean-Philippe BonjourPatrice Fardellone
Dec 22, 2007·Expert Review of Anticancer Therapy·Eric CheungJacek Pinski
Apr 11, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Manish GargSatya Narayan Sankhwar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.